id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0113-0003,FDA,FDA-2011-E-0113,FDA/CDER to U.S. Patent and Trademari Office - Letter,Other,LET-Letter,2011-04-25T04:00:00Z,2011,4,2011-04-25T04:00:00Z,,2011-04-25T19:54:16Z,,0,0,0900006480c37f5f
FDA-2011-E-0113-0002,FDA,FDA-2011-E-0113,U.S. Patent and Tradmark Office - Letter,Other,LET-Letter,2011-02-25T05:00:00Z,2011,2,2011-02-25T05:00:00Z,,2013-08-11T03:13:20Z,,0,0,0900006480bf7fcd
FDA-2011-E-0113-0001,FDA,FDA-2011-E-0113,Novartis Pharmaceuticals Corporation (Karen DeBenedictis) - Patent Extension Application,Other,APP-Application,2011-02-25T05:00:00Z,2011,2,2011-02-25T05:00:00Z,,2013-08-11T03:13:20Z,,0,0,0900006480bf7f4d